Wayne Shaw - Concepedia

Author

Wayne Shaw

Janssen (United States)

Also Known As

WAYNE SHAW, Wayne C Shaw, Wayne C. Shaw, Wayne Shaw

Publications

11.6K

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)The George Institute for Global Health Stanford University The University of Sydney Center for Clinical Research (United States)

About

Wayne Shaw is an author at Janssen (United States) specializing in medicine, cardiovascular disease, and hypertension.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.4K
2	Business	2	2	162
3	Management	2	2	162
4	Public Health	2	2	173
5	Anesthesia	1	1	10

Wayne Shaw

Publications

11.3K

Citations

H-Index

Page 1

	Year	Citations
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, New England Journal of Medicine	2017	7.5K
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials Vlado Perkovic, Dick de Zeeuw, Kenneth W. Mahaffey, The Lancet Diabetes & Endocrinology ObesityMetabolic SyndromeDiabetes ManagementUrologyHealth Policy	2018	632
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events Kenneth W. Mahaffey, Bruce Neal, Vlado Perkovic, Circulation	2017	494
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus Karin Rådholm, Gemma A. Figtree, Vlado Perkovic, Circulation	2018	469
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial Bruce Neal, Vlado Perkovic, Dick de Zeeuw, American Heart Journal HypertensionCardiovascular PharmacologyPlacebo-controlled TrialPharmacotherapyPreventive Cardiology	2013	331
Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes Bruce Neal, Vlado Perkovic, Dick de Zeeuw, Diabetes Care	2014	235
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal ( <scp>CANVAS‐R</scp> ): A randomized, placebo‐controlled trial Bruce Neal, Vlado Perkovic, David R. Matthews, Diabetes Obesity and Metabolism	2017	163
A Double‐Blind, Placebo‐Controlled, Dose‐Response Study of the Effectiveness and Safety of Enalapril for Children with Hypertension Thomas G. Wells, Virginia Frame, Beth A. Soffer, The Journal of Clinical Pharmacology	2002	152
Deposit Insurance and Wealth Effects: The Value of Being "Too Big to Fail" Maureen O’Hara, Wayne Shaw The Journal of Finance EconomicsMarket FailureFinancial SystemFinancial Risk ManagementDeposit Insurance	1990	148
Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes Jingwei Li, Mark Woodward, Vlado Perkovic, JACC Heart Failure	2019	137

Page 1